Magazine

Questions have swirled around the value of percutaneous coronary intervention (PCI) for patients whose quality of life has suffered from chronic total occlusion (CTO). Inevitably, another issue has arisen: which cath labs and operators should be undertaking these difficult and costly procedures?

The availability of a specialty drug doesn’t guarantee its accessibility, as cardiologists who try to prescribe PCSK9 inhibitors to their patients are learning. Insurers’ requirements for prior authorizations can create formidable barriers, but some providers have found ways to surmount them.

Some hospital systems are considering offering integrated vein care centers. One of the challenges they face is uncertainty about reimbursement.

With the passage of MACRA and introduction of new reimbursement models, hospitals are analyzing the costs and benefits of sending patients to skilled nursing facilities (SNFs).

Pediatric cardiologists say they can use telemedicine to improve patient care and ease the burden on patients’ families. But with the costs of these programs stretching into the hundreds of thousands, and a patchwork of reimbursement and regulations to contend with, what does it take to find success with pediatric telecardiology?

Cardiology’s Shark Tank will be back for its fourth year when TCT convenes Oct. 29-Nov. 2, in Denver. Program Director Juan F. Granada, MD, shares insights from the conference’s innovation competition.

The business of cardiology was at the forefront of discussion at the Society for Cardiovascular Angiography and Interventions (SCAI) Cath Lab Leadership Boot Camp in May. Speakers focused on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), bundled payment models and value-based reimbursement. Here are a few of the lessons attendees took back to their practices.

Recent medical group compensation and productivity data surveys fielded by AMGA suggest trends for practices to watch.

Why has the uptake of adjunctive diagnostic procedures like FFR, IVUS and OCT been slow? On the other hand, is there really a need for interventionalists to move beyond angiographic guidance?

Did the patent foramen ovale (PFO) cause the patient’s stroke? This, experts say, is the key question when deciding whether to recommend PFO closure. Heart–brain teams can help with the answer.   

As Medicare undergoes big changes, internally generated scorecards are becoming essential tools for physicians and practices to monitor performance and track progress toward goals.  

Sometimes the question you’re asked, or the one you heard, isn’t the one to answer—and other lessons learned in the data chasm.

Select an Issues